Peptide reference library

Peptide bioregulators (Khavinson peptides): the full list and the evidence

Checked at PubMed42 papersPublished by PepVault

Peptide bioregulators are short peptides and tissue extracts from Vladimir Khavinson’s institute in St. Petersburg, each said to regulate one organ. Of the 19 below, five have been compared with a control group in people, four were studied in people without one, and ten only in animals or cells.

Almost all of the research comes from the developers’ own group, much of it in Russian journals, and no large independent trial has confirmed a benefit in people.

Evidence level: early. The studies in people are small, mostly unblinded and almost all run by the developers; the rest is animal and cell work.

How far each has been tested

Compared with a control group in people: 5; Studied in people, no control group: 4; Animal studies only: 7; Cell studies only: 3Compared with a control group in people5Studied in people, no control group4Animal studies only7Cell studies only3
19 bioregulators, by the strongest kind of study published on each (PubMed, read November 18, 2026).
A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Track what you take in PepVault

Doses, vials, weight and side effects in one log.

Download on the App Store

7 days free on the yearly plan for new subscribers.

The full list, by system

Each row names the organ the peptide is aimed at in Khavinson’s scheme, the form it comes in and the strongest kind of study published on it, with the study’s own result and its PubMed record. A sequence is given where a PubMed-indexed paper publishes it; an extract is a mixture and has none.

Pineal gland and aging

BioregulatorSequenceAimed atFormStrongest study
EpithalaminAlso: Epithalamine, EpitalaminNone: a mixture of peptidesPineal gland: melatonin and the daily rhythmPeptide extract of animal tissue: a peptide preparation made from pineal glandsCompared with a control group in peopleIn a 12-year randomized study of older people with coronary disease (the abstract gives no group sizes), 28% fewer people died in the group given epithalamine than in the group on the same basic therapy alone. PubMed 17426848In a randomized study’s 15-year report, 39 patients given 6 courses over 3 years had lower mortality than 40 on basic therapy alone. PubMed 22451889The parent extract of Epitalon, and a different product: Epitalon is a synthetic copy of four of its amino acids.
EpitalonAlso: Epithalon, AEDG peptide, Ala-Glu-Asp-GlyAla-Glu-Asp-Gly (AEDG)Pineal gland, and the retinaSynthetic short peptideStudied in people, no control groupIn people with retinal degeneration it is reported to have helped in 90% of cases; the abstract describes no control group. PubMed 12195242Outside the developers’ group, a UK lab found it lengthened telomeres in normal human cells grown in the lab, through telomerase. PubMed 40908429

Immune system

BioregulatorSequenceAimed atFormStrongest study
ThymalinAlso: Timalin, ThymalineNone: a mixture of peptidesThymus and immunityPeptide extract of animal tissue: a drug made from calf thymus; its active parts include the dipeptides Lys-Glu and Glu-TrpCompared with a control group in peopleIn 266 older people followed for 6 to 8 years, deaths were 2.0 to 2.1 times fewer in the group given Thymalin than in the control group; the abstract does not describe the groups as randomized. PubMed 14523363Not thymulin, a different thymus peptide with a similar name.
ThymogenAlso: Timogen, Glu-Trp, EW dipeptide, IM862Glu-Trp (EW)ImmunitySynthetic short peptide: a drug, first isolated from ThymalinCompared with a control group in peopleIn a double-blind, placebo-controlled study of older people before abdominal cancer surgery, fewer complications followed in the Thymogen group (the abstract gives no group sizes). PubMed 21957588The same dipeptide, tested in the US as IM862 in 202 people with AIDS-related Kaposi sarcoma, did no better than placebo. PubMed 15598977
VilonAlso: Lys-Glu, KE dipeptideLys-Glu (KE)Thymus and immunitySynthetic short peptideStudied in people, no control groupAdded to standard care in people with type 1 diabetes, it lowered markers of abnormal blood clotting, less so in older patients with severe disease. PubMed 17152731
CrystagenAlso: KristagenNot publishedImmunitySynthetic short peptideCell studies onlyIn a lab study of aging spleen cells it activated B cells; the abstract does not name the species. PubMed 28976144

Brain and nerves

BioregulatorSequenceAimed atFormStrongest study
CortexinNone: a mixture of peptidesBrain cortexPeptide extract of animal tissue: an injected drug made from brain cortex, the parent of CortagenCompared with a control group in peopleIn a randomized study of 189 people with chronic poor blood flow to the brain, those given Cortexin had milder symptoms than those on basic treatment alone (no placebo). PubMed 30335070
CortagenAlso: AEDP peptide, Ala-Glu-Asp-ProAla-Glu-Asp-Pro (AEDP)Brain cortex and nervesSynthetic short peptideAnimal studies onlyIn rats with a cut and stitched sciatic nerve, the regrowing fibers grew 27% faster and carried signals 40% faster. PubMed 11276314
PinealonAlso: Glu-Asp-Arg, EDR peptideGlu-Asp-Arg (EDR)BrainSynthetic short peptideStudied in people, no control groupIn 32 people aged 41 to 83 with an organic brain syndrome, it moved measures of biological age, with no comparison group. PubMed 26390612

Heart and blood vessels

BioregulatorSequenceAimed atFormStrongest study
VesugenAlso: Vezugen, Lys-Glu-Asp, KED peptideLys-Glu-Asp (KED)Blood vesselsSynthetic short peptideStudied in people, no control groupIn 41 patients operated on for poor blood flow in the legs, blood flow was better after a course than before, with no comparison group. PubMed 28976154
CardiogenAlso: Ala-Glu-Asp-Arg, AEDR peptideAla-Glu-Asp-Arg (AEDR)HeartSynthetic short peptideAnimal studies onlyIn old rats with a transplanted sarcoma, it slowed the tumor’s growth through its blood supply. PubMed 20396706

Cartilage and bone

BioregulatorSequenceAimed atFormStrongest study
CartalaxAlso: Kartalax, Ala-Glu-Asp, AED peptideAla-Glu-Asp (AED)Cartilage and the musculoskeletal systemSynthetic short peptideAnimal studies onlyIn rats with bone loss after removal of the ovaries, it kept bone density from falling, less well than the cartilage extract did. PubMed 18306703

Lungs and airways

BioregulatorSequenceAimed atFormStrongest study
BronchogenAlso: Ala-Glu-Asp-Leu, AEDL peptideAla-Glu-Asp-Leu (AEDL)Bronchi and lungsSynthetic short peptideAnimal studies onlyIn rats with lung damage like COPD from nitrogen dioxide, a month of it reversed changes in the airway lining. PubMed 26468022
ChonlutenAlso: HonlutenNot publishedThe lining of the airwaysSynthetic short peptideCell studies onlyIn a human immune-cell line in the lab, it lowered the inflammatory signal TNF. PubMed 35408963

Liver, kidneys and pancreas

BioregulatorSequenceAimed atFormStrongest study
LivagenAlso: Lys-Glu-Asp-Ala, KEDA peptideLys-Glu-Asp-Ala (KEDA)LiverSynthetic short peptideAnimal studies onlyGiven by mouth to rats for two weeks, it moved the digestive enzymes of old rats toward the levels of young ones. PubMed 16075683
OvagenAlso: Glu-Asp-Leu, EDL peptideGlu-Asp-Leu (EDL)Liver and kidneysSynthetic short peptideAnimal studies onlyIn rats with two kinds of induced kidney injury, it protected kidney function. PubMed 28744634Its papers name it by its sequence, EDL.
PancragenAlso: Lys-Glu-Asp-Trp, KEDW peptideLys-Glu-Asp-Trp (KEDW)PancreasSynthetic short peptideCompared with a control group in peopleIn 33 older people with type 2 diabetes, fasting blood sugar and insulin resistance fell in those given it and not in those who weren’t; the abstract does not describe randomizing. PubMed 22448364

Prostate and testes

BioregulatorSequenceAimed atFormStrongest study
ProstamaxAlso: Lys-Glu-Asp-Pro, KEDP peptideLys-Glu-Asp-Pro (KEDP)ProstateSynthetic short peptideCell studies onlyIn blood cells from people aged 75 to 86, grown in the lab, it loosened tightly packed chromatin. PubMed 23221144
TestagenAlso: Lys-Glu-Asp-Gly, KEDG peptideLys-Glu-Asp-Gly (KEDG)TestesSynthetic short peptideAnimal studies onlyIn chickens and old hens whose pituitary was removed, the same sequence eased the changes in the thyroid. PubMed 22268052Those bird studies describe the sequence as modelled on pituitary extract; the developers’ 2021 review lists it as Testagen, for the testes.

The theory in plain words

Khavinson’s group proposes that short peptides of two to four amino acids act as signals: they pass into a cell and its nucleus, bind to particular stretches of DNA and change which genes are read, and each organ has peptides of its own. Their evidence is computer models of peptide and DNA fitting together, lab studies of labelled peptides entering the nucleus of human cells, and gene-expression changes in cells and animals.

Sources: Khavinson VK et al., Bull Exp Biol Med 2016, PubMed 27909961; Fedoreyeva LI et al., Biochemistry (Mosc) 2011, PubMed 22117547; Khavinson VK et al., Molecules 2021, PubMed 34834147

The idea grew from extracts: in the group’s early work, an extract of one tissue helped cultured pieces of that same tissue grow, and not other tissues. The synthetic peptides were then designed from the amino acids those extracts contain.

Sources: Khavinson VK, Bull Exp Biol Med 2001, PubMed 11713572; Khavinson VKh, Neuro Endocrinol Lett 2002, PubMed 12374906

Later papers from the group add a second piece: carrier proteins in the cell wall that move di- and tripeptides into cells, which they suggest explains why each peptide acts on its own tissue.

Sources: Khavinson V et al., Int J Mol Sci 2022, PubMed 35887081

What other groups have and haven’t reproduced

Reproduced elsewhere: a lab in London found that Epitalon lengthened telomeres in normal human cells through telomerase; a group in China found it protected mouse egg cells aging in a dish; and a US team found that Glu-Trp, the Thymogen dipeptide, slowed tumors in mice through natural killer cells.

Sources: Al-Dulaimi S et al., Biogerontology 2025, PubMed 40908429; Yue X et al., Aging (Albany NY) 2022, PubMed 35413689; Smith DL et al., Int J Cancer 2003, PubMed 12845648

Not reproduced: the gene-signal theory itself has not been tested by a group outside the developers’ circle, and no other group has repeated their long follow-up studies in people. The one bioregulator molecule taken through independent trials, Glu-Trp as IM862, did no better than placebo in a phase 3 trial of 202 people with Kaposi sarcoma, and produced no significant tumor responses in a phase 2 trial of 25 people with kidney cancer.

Sources: Noy A et al., J Clin Oncol 2005, PubMed 15598977; Deplanque G et al., Br J Cancer 2004, PubMed 15354209

An independent review in 2026 read the Epitalon and Epithalamin studies by design and size and called Epitalon biologically active but clinically unproven: no adequately powered randomized trial, and too little data on dose and long-term safety.

Sources: Jain A et al., Int J Mol Sci 2026, PubMed 42884164

The capsule lines: Cytomax and Cytogen

Two capsule lines carry the family into shops. Cytomax capsules hold peptide complexes extracted from animal tissue, one per organ, which the catalog calls natural peptide bioregulators; the developers’ papers describe these complexes as extracts of calf and cattle tissues. Cytogen capsules hold the synthetic short peptides, such as Vesugen, Pinealon, Ovagen and Chonluten.

The difference matters when you read a claim: an extract is a mixture of many peptides from an organ, while a Cytogen holds one known molecule, so a study of one doesn’t speak for the other. Both lines are sold as non-medicinal products, food supplements rather than drugs, so they were not reviewed for benefit the way a drug is. The injectable research vials sold online are a third thing again, from other makers.

On the extracts: Kuznik BI et al., Adv Gerontol 2020, PubMed 32362099; Khavinson V et al., Pharmaceuticals (Basel) 2021, PubMed 34071923; Linkova N et al., Int J Mol Sci 2023, PubMed 37176122. The product lines as their catalog listed them on November 18, 2026.

What isn’t known

What isn’t known is most of what a careful person would want to know first. No study has tracked long-term safety with modern methods, no independent study has found a dose, and the published amounts come from the developers’ own protocols. The human studies are small, rarely blinded and run by the group that makes the products, and most were published in Russian-language journals. That doesn’t make the findings false; it means they haven’t been checked.

Questions

What are peptide bioregulators?

They are short peptides, two to four amino acids long, and peptide extracts of animal organs, developed since the 1970s by Vladimir Khavinson’s group in St. Petersburg. In the group’s theory each one acts as a signal for one organ by changing which genes are read; this page lists 19 of them.

Are Khavinson peptides proven to work in humans?

Not to the standard of an approved drug. Five of the 19 here have been compared with a control group in people, in small studies mostly run by the developers. The one molecule of the family tested in independent trials, Glu-Trp (IM862), did no better than placebo in 202 people.

Do bioregulators make people live longer?

In an animal study, the pineal extract Epithalamin raised mean lifespan by 11 to 31% in fruit flies, mice and rats. In people, a study of 266 older adults followed for 6 to 8 years reported fewer deaths with Thymalin and Epithalamin than in a control group, and a randomized study of 79 heart patients reported lower mortality at 15 years; both came from the developers and neither has been repeated by another group.

Is Epitalon the same as Epithalamin?

No. Epithalamin is a peptide extract of pineal glands; Epitalon (Ala-Glu-Asp-Gly) is a synthetic four-amino-acid peptide designed from the amino acids of that extract. The long follow-up studies in people used Epithalamin, so they don’t transfer to Epitalon on their own.

What is the difference between Cytomax and Cytogen?

Cytomax capsules hold peptide extracts of animal tissue, one per organ; Cytogen capsules hold synthetic short peptides such as Vesugen and Pinealon. Both are sold as food supplements, not drugs.

Are bioregulators safe?

The short studies report few side effects, but no study has followed safety over years with modern methods, and no independent study has set a dose. The library’s entries for these peptides carry no reference dose for that reason.

Sources

  1. Korkushko OV et al., Bull Exp Biol Med 2006. Geroprotective effect of epithalamine (pineal gland peptide preparation) in elderly subjects with accelerated aging. PubMed 17426848
  2. Korkushko OV et al., Bull Exp Biol Med 2011. Peptide geroprotector from the pituitary gland inhibits rapid aging of elderly people: results of 15-year follow-up. PubMed 22451889
  3. Khavinson VKh, Neuro Endocrinol Lett 2002. Peptides and Ageing. PubMed 12374906
  4. Khavinson V et al., Neuro Endocrinol Lett 2002. Pineal-regulating tetrapeptide epitalon improves eye retina condition in retinitis pigmentosa. PubMed 12195242
  5. Al-Dulaimi S et al., Biogerontology 2025. Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. PubMed 40908429
  6. Khavinson VK et al., Molecules 2021. Peptide Regulation of Gene Expression: A Systematic Review. PubMed 34834147
  7. Khavinson VKh, Morozov VG, Neuro Endocrinol Lett 2003. Peptides of pineal gland and thymus prolong human life. PubMed 14523363
  8. Linkova N et al., Int J Mol Sci 2023. The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19. PubMed 37686182
  9. Smirnov VS et al., Adv Gerontol 2011. [Application thymogen for preoperative preparation of elderly patients with tumor processes in abdominal cavity]. PubMed 21957588
  10. Noy A et al., J Clin Oncol 2005. Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team. PubMed 15598977
  11. Anisimov VN et al., Biogerontology 2000. Immunomodulatory synthetic dipeptide L-Glu-L-Trp slows down aging and inhibits spontaneous carcinogenesis in rats. PubMed 11707921
  12. Kuznik BI et al., Adv Gerontol 2006. [Effect of thymomimetic vilon on blood coagulation system and fibrinolisis in diabetes mellitus type 1 patients of different age]. PubMed 17152731
  13. Chervyakova NA et al., Adv Gerontol 2014. [Molecular aspects of immunoprotective activity of peptides in spleen during the ageing process]. PubMed 28976144
  14. Fedin AI et al., Zh Nevrol Psikhiatr Im S S Korsakova 2018. [Dose-dependent effects of cortexin in chronic cerebral ischemia (results of a multicenter randomized controlled study)]. PubMed 30335070
  15. Anisimov SV et al., Neuro Endocrinol Lett 2004. Elucidation of the effect of brain cortex tetrapeptide Cortagen on gene expression in mouse heart by microarray. PubMed 15159690
  16. Turchaninova LN et al., Bull Exp Biol Med 2000. Effect of tetrapeptide cortagen on regeneration of sciatic nerve. PubMed 11276314
  17. Meshchaninov VN et al., Adv Gerontol 2015. [EFFECT OF SYNTHETIC PEPTIDES ON AGING OF PATIENTS WITH CHRONIC POLYMORBIDITY AND ORGANIC BRAIN SYNDROME OF THE CENTRAL NERVOUS SYSTEM IN REMISSION]. PubMed 26390612
  18. Kitachov KV et al., Adv Gerontol 2013. [The role of vasoactive peptid in lower limbs chronic arterial insufficiency treatment]. PubMed 28976154
  19. Levdik NV, Knyazkin IV, Bull Exp Biol Med 2009. Tumor-modifying effect of cardiogen peptide on M-1 sarcoma in senescent rats. PubMed 20396706
  20. Povorozniuk VV et al., Adv Gerontol 2007. [Effect of peptide regulators on the structural and functional status of bone tissue in ageing rats]. PubMed 18306703
  21. Kuzubova NA et al., Bull Exp Biol Med 2015. Modulating Effect of Peptide Therapy on the Morphofunctional State of Bronchial Epithelium in Rats with Obstructive Lung Pathology. PubMed 26468022
  22. Avolio F et al., Int J Mol Sci 2022. Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line. PubMed 35408963
  23. Timofeeva NM et al., Adv Gerontol 2005. [Effect of peptide Livagen on activity of digestive enzymes in gastrointestinal tract and non-digestive organs in rats of different ages]. PubMed 16075683
  24. Zamorskii II et al., Bull Exp Biol Med 2017. Nephroprotective Effect of EDL Peptide at Acute Injury of Kidneys of Different Genesis. PubMed 28744634
  25. Korkushko OV et al., Bull Exp Biol Med 2011. Prospects of using pancragen for correction of metabolic disorders in elderly people. PubMed 22448364
  26. Khavinson VKh et al., Bull Exp Biol Med 2010. Study of biological activity of Lys-Glu-Asp-Trp-NH2 endogenous tetrapeptide. PubMed 21246099
  27. Dzhokhadze TA et al., Georgian Med News 2012. [Deheterochromatinization of the chromatin in old age induced by oligopeptide bioregulator (Lys-Glu-Asp-Pro)]. PubMed 23221144
  28. Kuznik BI et al., Bull Exp Biol Med 2011. Effects of peptides Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly on hormonal activity and structure of the thyroid gland in hypophysectomized young chickens and old hens. PubMed 22268052
  29. Khavinson VK et al., Bull Exp Biol Med 2016. Short Peptides Regulate Gene Expression. PubMed 27909961
  30. Fedoreyeva LI et al., Biochemistry (Mosc) 2011. Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA. PubMed 22117547
  31. Khavinson VK, Bull Exp Biol Med 2001. Tissue-specific effects of peptides. PubMed 11713572
  32. Khavinson V et al., Int J Mol Sci 2022. Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers. PubMed 35887081
  33. Yue X et al., Aging (Albany NY) 2022. Epitalon protects against post-ovulatory aging-related damage of mouse oocytes in vitro. PubMed 35413689
  34. Smith DL et al., Int J Cancer 2003. Natural killer cell cytolytic activity is necessary for in vivo antitumor activity of the dipeptide L-glutamyl-L-tryptophan. PubMed 12845648
  35. Deplanque G et al., Br J Cancer 2004. Phase II trial of the antiangiogenic agent IM862 in metastatic renal cell carcinoma. PubMed 15354209
  36. Jain A et al., Int J Mol Sci 2026. Epitalon and Epithalamin: A Narrative Review of Mechanistic, Preclinical, and Clinical Evidence. PubMed 42884164
  37. Kuznik BI et al., Adv Gerontol 2020. [The influence of polypeptide liver complex and tetrapeptide KEDA on organism physiological function in norm and age-related pathology.]. PubMed 32362099
  38. Khavinson V et al., Pharmaceuticals (Basel) 2021. Neuroprotective Effects of Tripeptides-Epigenetic Regulators in Mouse Model of Alzheimer's Disease. PubMed 34071923
  39. Linkova N et al., Int J Mol Sci 2023. Peptide Regulation of Chondrogenic Stem Cell Differentiation. PubMed 37176122
  40. Anisimov VN et al., Mech Ageing Dev 1998. Pineal peptide preparation epithalamin increases the lifespan of fruit flies, mice and rats. PubMed 9701766
  41. Khavinson VKh et al., Adv Gerontol 2013. [Peptide bioregulators: the new class of geroprotectors. Message 2. Clinical studies results]. PubMed 24003726
  42. Khavinson VKh, Anisimov VN, Adv Gerontol 2009. [35-year experience in research of peptide regulation of aging]. PubMed 19827673

PepVault for iPhone

Track what you take in PepVault

Doses, vials, weight and side effects in one log.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo